Observations placeholder
Rivastigmine
Identifier
015703
Type of Spiritual Experience
Background
A description of the experience
Rivastigmine (sold under the trade name Exelon) is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer’s type and dementia due to Parkinson's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.
On Jan, 15, 2017 234 people reported to have side effects when taking Rivastigmine Tartrate. Among them, 8 people (3.42%) have Hallucination
On Dec, 24, 2016 1,170 people reported to have side effects when taking Rivastigmine. Among them, 31 people (2.65%) have Hallucination
Time on Rivastigmine when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 0.00% | 50.00% | 50.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Jan, 03, 2017 1,170 people reported to have side effects when taking Rivastigmine. Among them, 64 people (5.47%) have Death
Time on Rivastigmine when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 25.00% | 0.00% | 37.50% | 25.00% | 12.50% | 0.00% | 0.00% |
On Jan, 15, 2017 234 people reported to have side effects when taking Rivastigmine Tartrate. Among them, 5 people (2.14%) have Death
The source of the experience
eHealthmeConcepts, symbols and science items
Concepts
Symbols
Science Items
Activities and commonsteps
Activities
Overloads
Parkinsons disease drugsSuppressions
Dementia and AlzheimersParkinsons disease